Responsible for transitioning duties from former Chief Operating Officer role to support the Board and Chief Executive Officer with planning and execution requirements prior to leaving the Company at 2024 year-end.

Lead the development and execution of company-wide strategy and operations for a privately held global nutritional supplement company distributing products through licensed medical professionals. Responsible for business operations of Thorne HealthTech.• Increased revenues over 12 times over fourteen years; expanded international markets over twelve-fold; double digit growth planned for the next several years. Integrated four acquired businesses and launched 3 new business units. • Helped raise nearly $1 billion in capital and state/local business incentives. Co-led taking Company public and subsequently private.• Expanded production capacity eight-fold; reduced average shipping costs by over 50%; improved gross margin by over 10 percentage points. Lead the construction of and transition to a new facility over 2,600 miles across the U.S., relocating 40% of staff. Led subsequent five-fold expansion in operating square footage to over 750,000 sq. ft. • Streamlined product development and portfolio management leading to the development and launch of over 300 new products/line extensions; exited over 300 less productive products. • Led major technology and automation efforts. Reduced production waste by over 60% and quadrupled production output.• Recognized industry leader in quality. Improved quality and testing operations in cGMP plant, including multiple FDA, NSF and TGA audits with no 483’s or major issues; strengthening in-house testing, implementing formal stability, gluten-free and non-GMO testing programs.• Increased staff five-fold, implemented formal training, professional development and performance assessment programs, improved diversity, employee benefits, operating policies and implemented business risk management practices.

Provide strategy, analytical, pricing, reimbursement and operational consulting services and support to life sciences firms, including biopharmaceutical and medical device companies and private equity investors.

Lead the day to day operations of a private firm specializing in developing natural supplements as potential pharmaceutical compounds. Working to secure $50 - $60 million to fund a merger with a natural supplements company and to fuel a joint growth strategy. Will be COO of merged “NewCo”.

Appointed by CEO to lead company and industry-wide efforts to develop and implement new strategies, novel operating models, organizational designs, business process and productivity improvements.

Responsible for leading up to 400 staff and a $100 million budget for strategic planning, business analysis, public policy, market research, pricing and economics, marketing and sales support, direct to consumer marketing, medical affairs, trade relations, e-business and productivity.

Responsible for managed care and physician group sales, customer marketing, disease management, outcomes research, medical information technology, and provider support services through 150 person staff and $50 million budget.

Managed staff of over 50 to develop and provide disease and practice management programs and health economics research to US health care payers and providers.

Reported to the President, responsible for cross-business and functional planning and analysis for U.S. Pharmaceuticals.

Reporting to U.S. President, responsible for developing and implementing novel applications of information technology to support business operations, customer relations and business development opportunities.

Established and grew an analytical and operations support function through the following roles of increasing responsibility and staff:Director, Contracts and Compliance, 1/93 – 1/94Senior Manager, Managed Care Sales, 6/92 – 1/93Manager, Managed Health Care Sales, 3/92 – 6/92

Licensed agent, responsible for personal and commercial marketing and sales within a family insurance agency.

Responsible to senior management and outside parties for financial planning, reporting and analysis.

Member of three member team in the creation of managed care organization responsible for overseeing the analysis of business opportunities in the area of managed care.

Responsible for financial analysis and counsel to senior management.

Responsible for financial analysis and support for cardiovascular products, representing the Company’s largest business and product lines.

Responsible to the President, U.S. Ethical Pharmaceuticals and senior sales management for sales force planning, market and performance assessment and incentive compensation.

Responsible for sales and financial analysis and support for late stage U.S. pharmaceutical products.

Responsible for credit and receivable analysis, the approval of commercial credit, collections and cash forecasting while participating in the General Electric Financial Management Program.